LGND (Ligand Pharmaceuticals) Earnings per share growth rate in current year

Official company branding of Ligand Corp (LGND)

Ligand Pharmaceuticals (LGND) maintains high profitability based on Captisol, which creates long-term customer dependency through royalties. The annual EPS growth rate illustrates this trend, where 17.70 determines the current value of the metric. Revenues rely on the success of partner drugs, while a high-margin payment collection model ensures a stable cash flow, eliminating operational risks associated with technological obsolescence.

LGND (Ligand Pharmaceuticals Incorporated) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for ligand.com (LGND)

Fundamental valuation:Ligand Pharmaceuticals
Mass-produced product of Ligand Pharmaceuticals

Through its royalty model, Ligand Pharmaceuticals (LGND) eliminates manufacturing costs, converting partner sales into high-margin revenue. The current annual net income growth per share in percentage terms is 17.70, which reflects the EPS dynamics over twelve months and allows investors to filter out market noise to assess the real efficiency of business scaling and the stability of the company's fundamental growth rates.

Main competitors

Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|AMRX (Amneal) - Earnings per share increase in current year|Earnings per share growth in current year Perrigo PRGO|Earnings growth in current year Alvotech Biopharmaceuticals ALVO|liquidia.com - Earnings growth in current year|GLPG - Earnings growth in current year|ANIP: Earnings growth in current year|Earnings per share growth this year MNKD|AMPH (Amphastar) - Earnings growth in current year|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals